vimarsana.com

Page 5 - ஆராய்ச்சியாளர்கள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Daily Covid tests for school kids just as effective as sending them home, study reveals in push to end pingdemic

YOU RE KID-DING Daily Covid tests for school kids just as effective as sending them home, study reveals in push to end pingdemic Updated: 23:14, 22 Jul 2021 TESTING schoolkids for Covid daily is just as effective as sending them home, a study has revealed. More than a million children are needlessly out of class due to the virus this week after months of disrupted education. 2 Schoolchildren have suffered months of disrupted educationCredit: PA Researchers at Oxford University found 98.4 per cent of children who were told to isolate for 10 days never went on to test positive for coronavirus, The Telegraph reports. Schools that conducted daily tests instead of sending pupils home saw four per cent fewer cases.

Daily Covid tests for students found to be as effective as group isolation

Fri 23 Jul 2021 01.01 EDT Scientists have recommended daily tests for students who come into contact with Covid cases at secondary schools and colleges after finding that it prevents the spread of infection as much as sending whole bubbles home to isolate. Researchers at Oxford University compared the two approaches in 201 schools and colleges between April and June this year. Daily testing with lateral flow devices appeared to marginally reduce symptomatic infections in the schools, but had a greater impact on lost education, reducing the number of absences by an estimated 20% to 39%. The results of the trial, commissioned by the government, suggests that switching to daily lateral flow tests instead of sending contacts of Covid cases home to self-isolate for 10 days may help keep students in school after the summer without exacerbating the spread of the virus.

The Fiji Times » Global quest underway to speed COVID-19 vaccine trials

Reuters Reuters 21 July, 2021, 2:10 pm Vials labelled Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen in this illustration picture taken May 2, 2021. REUTERS/Dado Ruvic CHICAGO, July 20 (Reuters) – Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection against the illness. Regulators already use such benchmarks – known as correlates of protection – to evaluate flu vaccines without requiring large, lengthy clinical trials.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.